We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Unique Handheld Diagnostic Device - First of its Type in the Marketplace
Product News

Unique Handheld Diagnostic Device - First of its Type in the Marketplace

Unique Handheld Diagnostic Device - First of its Type in the Marketplace
Product News

Unique Handheld Diagnostic Device - First of its Type in the Marketplace


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Unique Handheld Diagnostic Device - First of its Type in the Marketplace"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AgPlus Diagnostics has announced that the first functional prototype of the handheld AgPlus Diagnostics analytical platform is now fully operational and available for demonstration.

Delivering laboratory-grade, quantifiable results within just 10 minutes of sample application the portable AgPlus technology system has enormous potential in a wide variety of applications where a rapid, accurate and sensitive result is important for fast and reliable decision making.

The AgPlus Diagnostics platform utilizes electrochemical immunoassay technology in a patented microfluidic chip format.

The unique signalling and measurement system, based on the detection of amplified silver ions by anodic stripping voltammetry, allows extremely sensitive, accurate and quantifiable results to be obtained from a very small sample volume (50µl) within minutes.

The system does not rely on an optical based detection method, so no sample preparation is required, making it ideal for multiple sample types and for testing in a range of settings.

The first fully functional AgPlus technology prototype will demonstrate an assay for human Troponin I, a cardiac marker used in clinical settings.

The AgPlus Troponin I assay is currently showing a dynamic range of .1ng/ml - 50ng/ml with CVs <20% in a non-optimized format with assay run times of 10 minutes.

In addition, AgPlus tests for cortisol and testosterone are currently in development, which will be of value in sports science applications for developing more tailored training plans for athletes and to help reduce chances of Over Training Syndrome.

The technology has been developed so that it can be applied to new and established chemistries and the platform software is easily integrated into existing information management systems.

AgPlus Diagnostics foresee further potential for this technology in human (clinical and non-clinical) and veterinary diagnostics, as well as in environmental and military applications.

“The first working AgPlus technology system prototype is an important milestone for AgPlus Diagnostics, demonstrating the successful coming together of this novel diagnostic assay and its unique analytical platform to achieve a fully functional, portable system that can deliver accuracy and sensitivity that’s on a par with laboratory analyzers,” comments Chief Executive Officer, Keith Page.

AgPlus Diagnostics is seeking to develop partnerships and licensing agreements with collaborators in a variety of applications and business sectors.

Advertisement